Comments
Drug discovery research and development organisation, GVK Biosciences (GVK BIO), today announced that Astellas Pharma Inc (Tokyo:4503, “Astellas”) has extended and renewed its licence to access the GVK BIO SAR Databases (GOSTAR).
GOSTAR (GVK BIO Online Structure Activity Relationship (SAR) Database) is an online scientific database product of GVK BIO.
It integrates information on compounds from discovery and development stages and marketed drugs. Information provided includes SAR, toxicity, preclinical, clinical and structural data for over 5.1 million compounds and 16.7 million SAR points.
Mr Sreeni Devidas, Vice-President, Sales and Marketing, Informatics at GVK BIO, in a statement said: “We are excited that Astellas has decided to extend the licence to the GOSTAR database.
“The GOSTAR database is becoming an indispensible tool for scientists in drug discovery. Several publications that have used the GOSTAR data validate the utility of this product.”
Informatics at GVK BIO
The Informatics division is responsible for analysing data to transform chemical and biological patterns into knowledge. Informatics offers Custom Curation, Cheminformatics and Bioinformatics services to global clients. It also licences and sells databases to biotech and pharma companies.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.